Preterm labour--is bacterial vaginosis involved?
- PMID: 12040953
Preterm labour--is bacterial vaginosis involved?
Abstract
Objective: To assess the efficacy of treatment of bacterial vaginosis (BV) using metronidazole to reduce preterm labour in primigravidae and multigravidae with previous midtrimester abortion or preterm labour.
Design: Randomised controlled trial.
Setting: Tertiary academic hospital.
Method: Two different groups of patients were screened for BV at the first antenatal visit, namely primigravidae and high-risk multigravidae who had had a previous midtrimester abortion or preterm delivery. Patients where BV was diagnosed clinically or on Gram's stain of a smear taken from the posterior vaginal fornix, received either 400 mg metronidazole, or 100 mg vitamin C orally twice daily for 2 days. The Gram's stain was repeated after 4 weeks. If BV was found again, treatment with the same drug was repeated.
Outcome measures: Preterm delivery, birth weight and perinatal deaths.
Results: One thousand and five patients entered the study, but 40 were excluded for various reasons and 10 were lost to follow-up. There were 464 primigravidae, of whom 150 (32%) had BV. Except for the 5-minute Apgar score, no significant differences were found between primigravidae negative for BV and those who received either metronidazole or vitamin C. There were 491 high-risk multigravidae, of whom 127 (26%) had BV. The mean gestational age in the BV-negative group was 37 weeks, in contrast to 37.4 weeks in the vitamin C group and 35.6 weeks in the metronidazole group. Birth weights in these three groups were 2,752 g, 2,759 g and 2,475 g respectively, significantly less (P = 0.0109) in the metronidazole group in comparison with the BV-negative group. Delivery before 37 weeks occurred in 29% of high-risk multigravidae with no BV but in 24% of those who took vitamin C and in 43% who took metronidazole. Differences were significant between the BV-negative and metronidazole groups (P = 0.0231) and also between the metronidazole and vitamin C groups (P = 0.0274). Delivery before 28 weeks occurred in 4% of the high-risk multigravidae with no BV but in 10% of those with BV who took metronidazole. The difference was significant (P = 0.0430). Analysis for maximum likelihood estimates for preterm labour identified only previous preterm labour or midtrimester abortion as risk factors.
Conclusion: Metronidazole does not seem to reduce the prevalence of preterm labour when given for BV before 26 weeks' gestation.
Similar articles
-
[Bacterial vaginosis and spontaneous preterm birth].J Gynecol Obstet Biol Reprod (Paris). 2016 Dec;45(10):1247-1260. doi: 10.1016/j.jgyn.2016.09.014. Epub 2016 Oct 26. J Gynecol Obstet Biol Reprod (Paris). 2016. PMID: 27793493 Review. French.
-
A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.BJOG. 2006 Jan;113(1):65-74. doi: 10.1111/j.1471-0528.2005.00788.x. BJOG. 2006. PMID: 16398774 Clinical Trial.
-
Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: an enigma.APMIS. 2005 Apr;113(4):233-45. doi: 10.1111/j.1600-0463.2005.apm_01.x. APMIS. 2005. PMID: 15865604 Review.
-
Preterm labour--is Mycoplasma hominis involved?S Afr Med J. 2002 Mar;92(3):235-7. S Afr Med J. 2002. PMID: 12040954
-
Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.N Engl J Med. 2000 Feb 24;342(8):534-40. doi: 10.1056/NEJM200002243420802. N Engl J Med. 2000. PMID: 10684911 Clinical Trial.
Cited by
-
Cracking the Code: Investigating the Correlation between Aerobic Vaginitis and Preterm Labor.Medicina (Kaunas). 2024 Apr 18;60(4):648. doi: 10.3390/medicina60040648. Medicina (Kaunas). 2024. PMID: 38674294 Free PMC article. Review.
-
The association between non-viral sexually transmitted infections and pregnancy outcome in Latin America and the Caribbean: A systematic review.Heliyon. 2023 Dec 13;10(1):e23338. doi: 10.1016/j.heliyon.2023.e23338. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38187347 Free PMC article.
-
Understanding and Preventing Recurring Bacterial Vaginosis: Important Considerations for Clinicians.Int J Womens Health. 2023 Aug 9;15:1317-1325. doi: 10.2147/IJWH.S383333. eCollection 2023. Int J Womens Health. 2023. PMID: 37581202 Free PMC article. Review.
-
Antibiotic treatment of bacterial vaginosis to prevent preterm delivery: Systematic review and individual participant data meta-analysis.Paediatr Perinat Epidemiol. 2023 Mar;37(3):239-251. doi: 10.1111/ppe.12947. Epub 2023 Jan 18. Paediatr Perinat Epidemiol. 2023. PMID: 36651636 Free PMC article.
-
Sexually Transmitted Infections Treatment Guidelines, 2021.MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1. MMWR Recomm Rep. 2021. PMID: 34292926 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical